Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CNP vs GSK✓SelectedUSD · GSKCNP vs GSK performance historyLatest closeAs of-1.24%11/16
Stock and ETF performance explorer

CNP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.6%
GSK return
+64.4%
Excess return
-6.8%
Maximum drawdown
-18.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-0.1%-1.2%-1.2%
7D-0.3%-1.3%+1.0%-0.2%
30D+0.3%+2.7%-2.4%0.0%
3M+0.2%+2.7%-2.5%-0.2%
6M-0.9%+3.3%-4.3%-1.4%
YTD+7.9%+6.5%+1.5%+6.9%
1Y+4.7%+10.7%-6.0%+3.3%
3Y+57.6%+64.4%-6.7%+31.7%
All+57.6%+64.4%-6.8%+31.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling